Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in determining the metabolic...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Learn to Adapt for Self-Supervised Monocular Depth Estimation.

IEEE transactions on neural networks and learning systems·2023

Same author

<i>De novo</i> glycan sequencing by electronic excitation dissociation MS<sup>2</sup>-guided MS<sup>3</sup> analysis on an Omnitrap-Orbitrap hybrid instrument.

Chemical science·2023

Same author

Comparison of the retinal microvasculature between compressive and glaucomatous optic neuropathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2023

Same author

Distinct urban-rural gradients of air NO<sub>2</sub> and SO<sub>2</sub> concentrations in response to emission reductions during 2015-2022 in Beijing, China.

Environmental pollution (Barking, Essex : 1987)·2023

Same author

Evaluation of the <i>IP-10</i> mRNA release assay for diagnosis of TB in HIV-infected individuals.

Frontiers in cellular and infection microbiology·2023

Same author

CENPH overexpression promotes the progression, cisplatin resistance, and poor prognosis of lung adenocarcinoma via the AKT and ERK/P38 pathways.

American journal of cancer research·2023

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Chemical Cartography Approaches to Study Trypanosomatid Infection

Chemical Cartography Approaches to Study Trypanosomatid Infection

Published on: January 21, 2022

Metabolite interference in pharmacokinetic studies.

Mehran F Moghaddam¹, Jui-Hsiang Fan, Yang Tang

¹Celgene, 4550 Towne Centre Ct, San Diego, CA 92121, USA.

Drug Metabolism Letters

|April 10, 2009

Summary

Extended chromatography in biotransformation studies is crucial. It helps detect inseparable cis/trans metabolites, preventing inaccurate plasma concentration measurements in pharmacokinetic bioanalyses.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Published on: July 11, 2014

Related Experiment Videos

Last Updated: Jun 24, 2026

Chemical Cartography Approaches to Study Trypanosomatid Infection

Chemical Cartography Approaches to Study Trypanosomatid Infection

Published on: January 21, 2022

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis

Published on: July 11, 2014

Area of Science:

Pharmacokinetics and Drug Metabolism
Analytical Chemistry

Background:

Pharmacokinetic bioanalyses require accurate metabolite identification.
Short chromatographic methods may fail to separate structurally similar metabolites, leading to analytical challenges.

Purpose of the Study:

To highlight the importance of extended chromatography in biotransformation studies.
To report the detection of an unusual cis/trans metabolite using extended chromatography.

Main Methods:

Conducting biotransformation studies with extended chromatography.
Performing pharmacokinetic bioanalyses on rat plasma samples.

Main Results:

An unusual cis/trans metabolite was detected in rat plasma.
This metabolite was inseparable using a short chromatographic method, underscoring the need for longer methods.

Conclusions:

Extended chromatography is essential for accurate metabolite profiling in pharmacokinetic studies.
Short chromatographic methods can lead to the misidentification or underestimation of metabolites, impacting plasma concentration measurements.